Global Medtech UAE Healthcare Investment Basket 2025
The United Arab Emirates is making significant investments to upgrade its medical infrastructure, aiming to become a global healthcare destination. This basket provides exposure to the international US and EU-listed companies in pharmaceuticals, medtech, and digital health that supply this ambitious national project.
Your Basket's Financial Footprint
This basket's total market capitalisation is 1,715,711.323 (as provided) and is dominated by large-cap holdings that anchor its profile. That concentration implies generally lower volatility and closer tracking of broad-market moves.
- Large-cap dominance tends to lower volatility and produce steadier performance, aligning with broad-market movements rather than sharp swings.
- Suitable as a core holding for portfolio diversification; not intended as a short-term speculative trade.
- Expect steady long-term value; explosive short-term gains are less likely with concentrated large-cap exposure.
JNJ: $466.99B
PFE: $145.04B
AZN: $275.08B
- Other
About This Group of Stocks
Our Expert Thinking
The UAE is investing billions to transform its healthcare system into a world-class destination for medical tourism and advanced care. This ambitious national project relies heavily on international expertise and cutting-edge technology from global leaders in pharmaceuticals, medical devices, and digital health solutions.
What You Need to Know
This group focuses on established US and EU-listed companies that are directly supplying the UAE's healthcare modernisation. These are proven industry leaders with existing partnerships and operations in the region, offering exposure to this significant infrastructure development through the global supply chain perspective.
Why These Stocks
Each company was handpicked based on their direct involvement in the UAE's healthcare transformation. From AstraZeneca's research partnerships with Abu Dhabi to GE HealthCare's equipment supply agreements with the Ministry of Health, these stocks represent the key enablers of this national development initiative.
Why You'll Want to Watch These Stocks
Massive Infrastructure Spend
The UAE is investing billions in new hospitals and medical facilities, creating enormous demand for the advanced equipment and services these companies provide.
Medical Tourism Hub Ambitions
As the UAE positions itself as a global healthcare destination, these international suppliers stand to benefit from sustained, long-term growth in medical infrastructure.
Proven Regional Partnerships
These aren't speculative plays - each company already has established operations, partnerships, and supply agreements with UAE healthcare authorities and major hospital groups.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
AI Regulatory Changes Explained | Market Opportunities
Following Italy's order for Meta to allow competing AI chatbots on WhatsApp, a new investment landscape is emerging where regulatory actions foster open competition. This theme focuses on independent AI developers and platform integrators poised to thrive as major tech companies are prevented from monopolizing distribution channels.
AI Chip Investment (Ecosystem Play) Opportunities
Nvidia's record $20 billion deal to acquire Groq's inference technology marks a major consolidation event in the AI hardware industry. This could accelerate demand for alternative chip designers and the foundational semiconductor ecosystem as customers seek to de-risk their supply chains.
Specialty Chemicals: What's Next After BP Castrol Sale
BP's multi-billion dollar sale of its Castrol lubricants division to an infrastructure firm highlights a strategic shift by energy majors to streamline operations. The investment theme focuses on other specialized chemical and industrial companies that may benefit from similar divestitures or become targets for private capital seeking stable, infrastructure-like assets.